China Medical System Targets Secondary Listing on SGX to Expand Southeast Asia Reach

Hong Kong-listed pharmaceutical group China Medical System (CMS) has filed for a secondary listing on the Singapore Exchange (SGX) mainboard, with trading expected to commence in July 2025. The move is part of CMS’s...